Deepcell Overview

  • Founded
  • 2015
Founded
  • Status
  • Private
  • Employees
  • 50
Employees
  • Latest Deal Type
  • Series B
  • Latest Deal Amount
  • $73M
Latest Deal Amount
  • Investors
  • 11

Deepcell General Information

Description

Developer of diagnostic biotechnology intended to offer non-invasive genetic tests with diagnostic-level accuracy. The company's technology provides detailed genetic health information through ordinary blood sampling, enabling clients to eliminate the need for invasive diagnostic tests.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Healthcare Technology Systems
Discovery Tools (Healthcare)
Primary Office
  • 4025 Bohannon Drive
  • Menlo Park, CA 94025
  • United States

Deepcell Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Deepcell Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series B) 17-Mar-2022 $73M 00000 Completed Generating Revenue
3. Later Stage VC 07-Dec-2020 0000 0000 Completed Generating Revenue
2. Early Stage VC (Series A) 06-Sep-2019 $20M $25M 0000 Completed Startup
1. Seed Round 27-Dec-2017 $5M $5M 000.00 Completed Startup
To view Deepcell’s complete valuation and funding history, request access »

Deepcell Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-1 000,000 00.000000 00 000.00 000.00 00 000.00 00
Series A 000,000 00.000000 00 000.00 000.00 00 000.00 00.00
Seed 532,164 $0.000100 6% $9.4 $9.4 1x $9.4 15.66%
To view Deepcell’s complete cap table history, request access »

Deepcell Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of diagnostic biotechnology intended to offer non-invasive genetic tests with diagnostic-level accuracy. The c
Biotechnology
Menlo Park, CA
50 As of 2022
00000
00000000000 00000

00000000

iscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim ven
0000 000000000
Tampa, FL
0 As of 0000
000.00
0000000000.
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Deepcell Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
00000000 0000 0000 Formerly VC-backed Tampa, FL 0 000.00 0000000000.
You’re viewing 1 of 1 competitors. Get the full list »

Deepcell Patents

Deepcell Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3837527-A1 Systems and methods for particle analysis Pending 15-Aug-2018 000000000
US-10808219-B2 Systems and methods for particle analysis Active 15-Aug-2018 000000000 0
US-20200056142-A1 Systems and methods for particle analysis Granted 15-Aug-2018 000000000000 0
US-20210032588-A1 Systems and methods for particle analysis Granted 15-Aug-2018 000000000
US-10611995-B2 Systems and methods for particle analysis Active 15-Aug-2018 C12M47/04 0
To view Deepcell’s complete patent history, request access »

Deepcell Executive Team (7)

Name Title Board Seat Contact Info
Maddison Masaeli Ph.D Co-Founder & Chief Executive Officer
Mahyar Salek Ph.D Co-Founder, Chief Technology Officer, Chief Operating Officer, Board Member & President
Marc Montserrat Chief Business Officer
Euan Ashley Ph.D Co-Founder & Advisory Board Member
Catherine Blish MD Advisor
You’re viewing 5 of 7 executive team members. Get the full list »

Deepcell Board Members (3)

Name Representing Role Since
Blake Goodner Deepcell Board Member 000 0000
David Mauney MD Self Board Member 000 0000
Matthew Posard Self Board Member & Chief Strategist 000 0000
To view Deepcell’s complete board members history, request access »

Deepcell Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Deepcell Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Bridger Healthcare Venture Capital Minority 000 0000 000000 0
Casdin Capital Hedge Fund Minority 000 0000 000000 0
Horizons Ventures Venture Capital Minority 000 0000 000000 0
Koch Disruptive Technologies Corporate Venture Capital Minority 000 0000 000000 0
Matt Mcllwain Angel (individual) Minority 000 0000 000000 0
You’re viewing 5 of 11 investors. Get the full list »